Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
Eryk LatochKatarzyna KonończukKatarzyna Taranta-JanuszKatarzyna Muszyńska-RosłanEdyta SzymczakAnna WasilewskaMaryna Krawczuk-RybakPublished in: Cancer chemotherapy and pharmacology (2020)
We demonstrated that ALL survivors have higher levels of urine NGAL, NGAL/cr. and uKIM-1/cr. ratio as compared to the control group. Further long-term follow-up studies are necessary to assess the significance of the NGAL and KIM-1 and their relationship to kidney damage after anticancer treatment in childhood.